about
Angiogenesis and antiangiogenic agents in cervical cancer.Triple-negative breast cancer: new perspectives for targeted therapies.Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer.Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC).Correlation between fertility drugs use and malignant melanoma incidence: the state of the art.Triple-negative breast cancer: investigating potential molecular therapeutic target.Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment
P50
Q34655335-6964F371-8EA1-4237-992C-EBC753A8AD91Q35001758-1A81745F-420E-4F4E-A827-C94307D3621DQ38151193-A6667037-C984-425E-853B-916A8D85B9E2Q38176601-DD9AEEDB-D08E-407A-B758-BA8327C58745Q38223603-62FCD2E5-5785-41F7-81AF-8E95B39B794CQ38259322-EAB04B7B-AF13-44D3-BFEE-5E8CA09099FBQ38631272-58A39D8E-BE75-41D1-BDE2-6DC523C2F17CQ95723202-09449BD5-E615-48AA-AB58-0BF71BA4E1EC
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Davide Caruso
@ast
Davide Caruso
@en
Davide Caruso
@es
Davide Caruso
@nl
Davide Caruso
@sl
type
label
Davide Caruso
@ast
Davide Caruso
@en
Davide Caruso
@es
Davide Caruso
@nl
Davide Caruso
@sl
prefLabel
Davide Caruso
@ast
Davide Caruso
@en
Davide Caruso
@es
Davide Caruso
@nl
Davide Caruso
@sl
P106
P21
P31
P496
0000-0001-8622-8142